To understand the role of HPV16/18 in the degradation of Rap1GAP, HPV16/18 positive cervical cancer cell lines, HeLa (containing HPV18) and SiHa (containing HPV1 6), and an HPV-negative cervical cancer cell line, C33A, were used in the study. The gene discussed is RAP1GAP; the disease is cervical carcinoma.